CD24在肾透明细胞癌多中心病灶和单结节中的表达及意义
摘要
目的:观察 CD24在肾透明细胞癌多中心病灶及单结节病灶中的表达情况,探讨其在多中心病灶发生机制中的意义。方法收集完整的肾透明细胞癌根治术后标本,多中心病灶16例,单结节14例。检测CD24在肾透明细胞癌多中心病灶及单结节病灶中的表达情况。结果在肾透明细胞癌多中心病灶组CD24阳性表达率为100%;肾透明细胞癌单结节病灶组阳性表达率78.6%,CD24在两组的表达有显著性差异,P<0.01;16例多中心病灶中有15例原发肿瘤直径大于4 cm,占该组病例的93.8%;14例单结节组中有6例原发肿瘤直径大于4 cm,占该组病例的42.9%,两组差异有统计学意义,P<0.01;两组病例的病理分级对比发现多中心病灶组高分级(病理分级2~3级)为100%,单结节灶组高分级为85.7%,这两组在病理分级上差异无统计学意义,P>0.05。结论 CD24在肾透明细胞癌多中心病灶组表达明显高于单结节病灶组的表达,提示CD24高表达与肾透明细胞癌多中心病灶发生成正相关,多中心病灶发生可能是由肾内转移而来。
出处
《中华临床医师杂志(电子版)》
CAS
2013年第14期231-232,共2页
Chinese Journal of Clinicians(Electronic Edition)
参考文献9
-
1Junker K,Schlichter A,Hindermann W. Genetic characterization of multifocal tumor growth in renal cell carcinoma[J].Kidney International,1999.1291-1294.
-
2李泉林,关宏伟,张秋萍,薛军,王法鹏,高鹤立,韩辉,张仁科.肾癌多中心病灶发生机理的探讨[J].中华泌尿外科杂志,2003,24(4):232-234. 被引量:29
-
3Fogel M,Friederichs J,Zeller Y. CD24 is a marker for human breast carcinoma[J].Cancer Letters,1999,(1):87-94.doi:10.1016/S0304-3835(99)00195-0.
-
4Friederichs J,Zeller Y,Hafezi-Moghadam A. The CD24/P-selectin binding pathway initiates lung arrest of human A125 adenocarcinoma cells[J].Cancer Research,2000.6714-6722.
-
5Baumann P,Cremers N,Kroese F. CD24 Expression Causes the Acquisition of Multiple Cellular Properties Associated with Tumor Growth and Metastasis[J].Cancer Research,2005.10783-10793.
-
6张永红,曾甫清.肾细胞癌中CD24蛋白的表达及其临床意义[J].临床泌尿外科杂志,2007,22(3):219-220. 被引量:2
-
7Kletscher BA,Qian J,Bost wick DG. Prospective analysis of multifocality in renal cell carcinoma:influence of histological pattern,grade,number,size,volume and deoxyribonucleic acid ploidy[J].Journal of Urology,1995.904-906.
-
8Gohji K,Hara I,Gotoh A. Multifocal renal cell carcinoma in Japanese patients with tumors with maximal diameter of 50 mm or less[J].Journal of Urology,1998.1144-1147.
-
9Uzzo RG,Novick AC. Nephr on sparing surgery for renal tumors:indications,techniques and outcomes[J].Journal of Urology,2001.6-18.
二级参考文献15
-
1Junker K, Schlichter A, Hindermann W, et al. Genetic characterization of multifocal tumor growth in renal cell carcinoma. Kidney Int, 1999,56 : 1291-1294.
-
2Haitel A, Wiener HG, Blasehitz U, et al. Biologic behavior of p53 overexpression in multifocal renal cell carcinoma of clear cell type.Cancer, 1999,85 : 1593-1598.
-
3Morel QL, Clar BF, Fenollosa EB, et al. Proliferating cell nuclear antigen (PCNA) as a prognostic factor in renal cell carcinoma. Anticancer Res, 1998,18:677-682.
-
4Paradis V, Ferlicot S, Ghannam E, et al. CD44 is an independent prognostic factor in conventional renal cell carcinoma. J Urol, 1999,16 :1984-1987.
-
5Stumm G, Eberwein S, Rostock-Wolf S, et al. Concomitant overexpression of the EGFR and erb B2 genes in renal cell carcinoma(RCC) is correlated with dedifferentiation and metastasis. Int J Cancer, 1996,69:17-22.
-
6Eschewege P,Saunsine C,Delepaul B,et al. Radical nephrectomy for renal cell carcinoma 30 mm or less :long-term followup results. J Urol,1996,155 : 1196-1199.
-
7Figarella-Branger D, Moreau H, Pellissier J F, et al. CD24, a signal-transducing molecule expressed on human B lymphocytes, is a marker for human regenerating muscle[J]. Acta Neuropathol (Berl),1993, 86: 275-284.
-
8Jackson D, waibel R, Weber E, et al. A CD24, a signal-transducing molecule expressed on human b cells, is a major surface antigen on small cell lung carcinomas [J]. Cancer Res, 1992, 52: 5261-5270.
-
9Senner V, Sturm A, Baur I, et al. CD24 promotes in vasion of blioma cells in vivo[J]. J Neuropathol Exp Neurol, 1999, 58: 795-802.
-
10Kristiansen G, Denkert C, Xchluns K, CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival[J]. American Journal of pathology, 2002, 161: 1215-1221.
共引文献29
-
1刘之俊,符伟军,綦海燕,孙小庆,祝海.保留肾单位肾癌切除术后二例早期复发[J].肿瘤研究与临床,2008,20(6):410-411.
-
2韩希年,彭令荣.多发肾细胞癌的影像学诊断[J].临床放射学杂志,2005,24(5):415-418. 被引量:6
-
3韩希年,彭令荣,刘光华,王俭.肾透明细胞癌的CT、MRI诊断[J].中国医学影像技术,2005,21(5):776-778. 被引量:24
-
4韩希年,彭令荣,刘光华,王俭.乳头状肾细胞癌的CT表现[J].第二军医大学学报,2005,26(7):827-828. 被引量:2
-
5赵高贤,刘彦军,张卫星,徐培元.保留肾单位手术治疗肾癌的临床分析(附19例报告)[J].中国综合临床,2006,22(7):650-651. 被引量:4
-
6刘广华,李汉忠,夏溟,纪志刚,谢毅.多中心肾癌发生机制探讨[J].临床泌尿外科杂志,2006,21(8):579-581. 被引量:8
-
7李泉林(综述),刘用戢(审校).有关肾细胞癌多中心病灶的若干问题[J].国际泌尿系统杂志,2007,27(1):26-29. 被引量:2
-
8杜联芳,李凡,邢晋放,白敏,陈惠莉,路光中.新型超声造影剂声诺维在小肾癌诊断中的应用[J].中华泌尿外科杂志,2007,28(1):61-61. 被引量:3
-
9韩希年,彭令荣,刘光华,王俭.300例肾细胞癌CT表现分析[J].中华放射学杂志,2007,41(5):510-513. 被引量:34
-
10韩希年,彭令荣,刘光华,王俭.100例小肾癌螺旋CT多期扫描分析[J].中华肿瘤杂志,2007,29(5):382-385. 被引量:20
-
1陈大鹏,牛玉军,谢美艳,李铁.胃间质瘤CT征象与危险度分级的关系[J].解放军医学院学报,2016,37(5):461-464. 被引量:5
-
2张贵成.不同年龄乳腺癌患者的临床病理分析[J].中国实用医药,2011,6(19):131-132. 被引量:4
-
3韩超,韩东明.肾脏囊性占位病变CT及MRI表现与Bosniak分级对比[J].中国社区医师,2015,31(10):96-96. 被引量:3
-
4王芃,李铁男,黄山,郎晓峰,李挪,刘伟,张铁岩.破裂颅内动脉瘤的急诊治疗[J].中国社区医师(医学专业),2014,16(22):24-25. 被引量:3
-
5高晓,吴宏培,张冠军.63例卵巢浆液性癌的MDACC分级及临床病理意义[J].医学临床研究,2016,33(3):507-509. 被引量:1
-
6关超,柳斌,于靖寰,冯勇.喉癌颈部淋巴结触诊阳性对N分级的参考价值[J].临床耳鼻咽喉科杂志,1999,13(9):390-391. 被引量:1
-
7陈翰高,龙莉玲,李茂,崔惠勤,李文美.MR增强检查对幕上星形胶质细胞瘤分级的价值[J].暨南大学学报(自然科学与医学版),1998,19(6):78-78.
-
8徐英,徐爱民.重度阻塞性肺病患者食管癌切除同期肺减容手术临床探讨[J].黑龙江医学,2001,25(8):563-564. 被引量:1